[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 568197, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 222228, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 388899, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 568279, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.1, "dayLow": 1.0701, "dayHigh": 1.13, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.1, "regularMarketDayLow": 1.0701, "regularMarketDayHigh": 1.13, "payoutRatio": 0.0, "forwardPE": -3.548387, "volume": 194348, "regularMarketVolume": 194348, "averageVolume": 191680, "averageVolume10days": 122370, "averageDailyVolume10Day": 122370, "bid": 0.8136, "ask": 1.38, "bidSize": 2, "askSize": 2, "marketCap": 90914664, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 3.12, "fiftyDayAverage": 1.05184, "twoHundredDayAverage": 1.49801, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 67727848, "profitMargins": 0.0, "floatShares": 78707369, "sharesOutstanding": 82649696, "sharesShort": 2015728, "sharesShortPriorMonth": 1845780, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.024400001, "heldPercentInsiders": 0.043509997, "heldPercentInstitutions": 0.10231, "shortRatio": 11.03, "shortPercentOfFloat": 0.0253, "impliedSharesOutstanding": 83017800, "bookValue": 0.213, "priceToBook": 5.1643195, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -35785320, "trailingEps": -0.34, "forwardEps": -0.31, "enterpriseToEbitda": -1.686, "52WeekChange": -0.5309168, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 1.1, "targetHighPrice": 10.104826, "targetLowPrice": 8.134964, "targetMeanPrice": 8.928928, "targetMedianPrice": 8.546989, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 23292700, "totalCashPerShare": 0.282, "ebitda": -40174764, "totalDebt": 150660, "quickRatio": 3.05, "currentRatio": 3.261, "debtToEquity": 0.857, "returnOnAssets": -0.89032, "returnOnEquity": -1.9011, "freeCashflow": -13849695, "operatingCashflow": -25291840, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1748042542, "regularMarketTime": 1748030401, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "regularMarketChangePercent": 2.8037355, "regularMarketPrice": 1.1, "postMarketChangePercent": 2.60909, "postMarketPrice": 1.1287, "postMarketChange": 0.0287, "regularMarketChange": 0.029999971, "regularMarketDayRange": "1.0701 - 1.13", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 191680, "fiftyTwoWeekLowChange": 0.329, "fiftyTwoWeekLowChangePercent": 0.42671853, "fiftyTwoWeekRange": "0.771 - 3.12", "fiftyTwoWeekHighChange": -2.02, "fiftyTwoWeekHighChangePercent": -0.6474359, "fiftyTwoWeekChangePercent": -53.091682, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.34, "epsForward": -0.31, "epsCurrentYear": -0.52, "priceEpsCurrentYear": -2.1153848, "fiftyDayAverageChange": 0.048160076, "fiftyDayAverageChangePercent": 0.045786507, "twoHundredDayAverageChange": -0.39801002, "twoHundredDayAverageChangePercent": -0.2656925, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.8 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]